SELECTING CANCER MUTATIONS TO CREATE PERSONALIZED CANCER VACCINE Russian patent published in 2023 - IPC G16B20/50 G16B35/10 

Abstract RU 2809620 C2

FIELD: molecular biology.

SUBSTANCE: method for selecting tumor neoantigens for use in a personalized vaccine is described. Neoantigens are determined in a sample of cancer cells taken from an individual, wherein each neoantigen is contained in a coding sequence, contains at least one mutation in the coding sequence resulting in a change in the encoded amino acid sequence that is not present in a sample of non-cancerous cells of the specified individual, and consists of 9 to 40 contiguous amino acids of the coding sequence in a sample of cancer cells. For each neoantigen, the frequencies of mutant alleles of each of the specified mutations in the coding sequence are determined. The expression level of each coding sequence is determined in a sample of cancer cells or based on a cancer expression database of the same type as the sample of cancer cells. The binding affinity of the neoantigens to MHC class I is predicted. The neoantigens are ranked according to the values previously determined for each neoantigen, from the largest to the smallest value, providing the first, second and third list of ranks. The rank sum is calculated based on the first, second and third list of ranks and the distribution of neoantigens based on increase of the rank sum to obtain a ranked list of neoantigens, wherein the rank sum is a weighted rank sum, where the number of neoantigens is added to the rank value of each neoantigen. 30-240 neoantigens are selected from a ranked list of neoantigens, starting with the lowest rank. A method for constructing a personalized vector encoding a list of neoantigens selected by the method for use in form of a vaccine is also described. An expression vector encoding a list of neoantigens is presented. A collection of expression vectors is presented, each of which encodes part of the list of neoantigens.

EFFECT: claimed invention expands the arsenal of drugs for treating cancer.

15 cl, 8 dwg, 9 tbl, 4 ex

Similar patents RU2809620C2

Title Year Author Number
METHOD FOR TREATING CANCER 2016
  • Makgranakhan Nikolas
  • Rozental Rejchel
  • Svonton Charlz
  • Peggz Karl
  • Kesada Serkhio
RU2770447C2
IDENTIFICATION, PRODUCTION AND USE OF NEOANTIGENS 2016
  • Yelensky Roman
  • Derti Adnan
  • Bulik-Sullivan Brendan
  • Busby Jennifer
RU2729116C2
PREDICTION OF IMMUNOGENICITY OF T-CELL EPITOPES 2014
  • Sakhin Ugur
  • Tadmor Arbel David
  • Kasl Dzhon Kristofer
  • Begel Sebastyan
  • Lever Martin
RU2724370C2
VACCINE COMPOSITION FOR TREATMENT OF CANCER 2018
  • Nikosia, Alfredo
  • Skarselli, Elisa
  • D'Alise, Anna Morena
RU2782261C2
METHODS OF PREDICTING THE APPLICABILITY OF DISEASE-SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY 2018
  • Sakhin, Ugur
RU2799341C2
NEOANTIGEN VECTORS BASED ON ALPHAVIRUS 2018
  • Blejr, Uejd
  • Joss, Karin
  • Rappaport, Emi Rejchel
  • Skallan, Siaran Daniel
  • Gitlin, Leonid
RU2803566C2
COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF 2016
  • Fritsch, Edward, F.
RU2753246C2
INVARIANT CHAIN CANCER VACCINE FROM TELEOST FISH 2019
  • Nikosia, Alfredo
  • Skarselli, Elisa
  • Lam, Armin
RU2808567C2
INDIVIDUALISED VACCINES FOR CANCER 2012
  • Sakhin Ugur
  • Krajter Sebastyan
  • Diken Mustafa
  • Dikmann Yan
  • Kozlovski Mikhael
  • Britten Tsedrik
  • Kestl Dzhon
  • Lever Martin
  • Renard Bernkhard
  • Omokoko Tana
  • De Graf Jokhannes Khendrikus
RU2670745C9
AMPLIFIER T-CELL RESPONSE TO VACCINE 2018
  • Nikosia, Alfredo
  • Skarselli, Elisa
  • Folgori, Antonella
  • Lam, Amin
RU2794196C2

RU 2 809 620 C2

Authors

Nikosia, Alfredo

Skarselli, Elisa

Lam, Armin

Leoni, Gvido

Dates

2023-12-13Published

2019-11-15Filed